)
Company research29 Apr 2026
Target Corporation: The Business Behind the Bullseye
How Target grew from a Minneapolis dry goods store into a retail giant, blending discount pricing with design and private-label power.
Maze Therapeutics
Maze Therapeutics (MAZE) investor relations material
Maze Therapeutics Proxy filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Proxy filing summary28 Apr, 2026
Executive summary
Annual meeting scheduled for June 8, 2026, with voting available online or virtually.
Shareholders are encouraged to review proxy materials and vote by June 7, 2026.
Voting matters and shareholder proposals
Election of two Class I director nominees: Jason Coloma, Ph.D., and Neil Kumar, Ph.D.
Ratification of Ernst & Young LLP as independent registered public accounting firm for fiscal year ending December 31, 2026.
Board recommends voting "For All" director nominees and "For" auditor ratification.
Other business may be addressed as appropriate during the meeting.
Board of directors and corporate governance
Board slate includes two Class I director nominees up for election at the annual meeting.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Maze Therapeutics
- Director elections and auditor ratification headline a meeting focused on governance and oversight.MAZE
Proxy filing28 Apr 2026 - Lead programs show promising clinical progress in AMKD, PKU, and CKD, with robust financial support.MAZECorporate presentation28 Apr 2026
- MZE829 reduced proteinuria by 36% in AMKD, showing strong efficacy and safety.MAZEStudy result25 Mar 2026
- Strong clinical progress and $360M cash position support pipeline advancement into 2028.MAZEQ4 202525 Mar 2026
- Multiple clinical catalysts in kidney and metabolic diseases expected this year, with strong funding.MAZETD Cowen 46th Annual Health Care Conference4 Mar 2026
- MZE829 and MZE782 advance toward key data and phase 2 studies, targeting major kidney and metabolic needs.MAZEGuggenheim Securities Emerging Outlook: Biotech Summit 202612 Feb 2026
- Phase II data for APOL1 kidney disease and PKU/CKD programs expected in 2026, fully funded.MAZE44th Annual J.P. Morgan Healthcare Conference12 Jan 2026
- Advancing precision therapies for kidney and metabolic diseases with strong near-term catalysts.MAZECorporate presentation12 Jan 2026
- Pivotal kidney disease data and dual PKU/CKD phase 2 trials are set for 2026.MAZEGuggenheim Securities 2nd Annual Healthcare Innovation Conference7 Jan 2026
Next Maze Therapeutics earnings date
Q1 202614 May, 2026
Maze Therapeutics
Next Maze Therapeutics earnings date
Q1 202614 May, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
Related articles
)
Business philosophy23 Apr 2026
Greg Foran: The New CEO of Kroger
How Greg Foran rose from store floor to CEO of Kroger, led Walmart's turnaround, and built a leadership style focused on execution.
)
Company research22 Apr 2026
Companies That Had Their IPO in 2025: The IPO Market Recovers
After years of uncertainty, 2025 marked the IPO market's return, with major listings like Klarna and Figma signaling renewed momentum.
Frequently asked questions
Explore our global coverage